Neuromuscular Disease
50
5
6
28
Key Insights
Highlights
Success Rate
82% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
12.0%
6 terminated out of 50 trials
82.4%
-4.2% vs benchmark
4%
2 trials in Phase 3/4
18%
5 of 28 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 28 completed trials
Clinical Trials (50)
Electrical Impedance Myography: Natural History Studies inNeuromuscular Disorders and Healthy Volunteers
Feasibility of Virtual Reality in Children With Neuromuscular Disease, Effectiveness of Virtual Reality and Biofeedback
A Clinical Trial of Early Ventilation in Amyotrophic Lateral Sclerosis (EVENT ALS)
A Phase 3 Study of NTLA-2001 in ATTRv-PN
Connect-One: Early Feasibility Study of Connexus® Brain-Computer Interface (BCI)
Manual Therapy and Inspiratory Muscle Training in Neuromuscular Disease
Ultrasound Detection of Early Facial Muscle Changes in FSHD: Thickness and Echo Intensity Findings
B3 for NMD: Bench to Bedside and Back
The Effects of a Dynamic Arm Support in Daily Life
Hyperthermia in Patients With Chronic Primary Pain - Effects on Thermoregulation, Somatosensory System and Movement Evoked Pain
Validation and Scaling of Screening Program for Undiagnosed Myasthenia Gravis-Social Media Campaign Paired With a Self-moderated Assessment
New Technological Pathway for Gait Rehabilitation
The Prevalence of RYR1-related Disease
Genetics of Pediatric-Onset Motor Neuron and Neuromuscular Diseases
Overview: Use of Respiratory Support At Home in Children
Ultrasonographic Muscle Assessment and Functional Scales in Spinal Muscular Atrophy
Respiratory Muscle Strength in Patients With NMD
A Study to Investigate the Effects of Heated Humidification During Non-Invasive Ventilation
Autotitrating Versus Standard Non-invasive Ventilation (NIV) in Newly Diagnosed Patients
Juno Perth Clinical Trial